To enable the analysis of anything, by anyone, anywhere
Oxford Nanopore Technologies plc, a spin-out from the University of Oxford founded in 2005, revolutionizes DNA/RNA sequencing with its innovative technology. Led by CEO Dr. Gordon Sanghera, the company boasts over 1000 multidisciplinary employees. Their cutting-edge sequencing platform offers real-time analysis from portable to population-scale, capable of sequencing native DNA/RNA fragments of any length, delivering rapid insights and disrupting conventional biological analyses for societal benefit.
Small formats such as Flongle address the need for on-demand, rapid, smaller tests or experiments and can be used in labs or in the field. The pocket-sized MinION is a powerful and portable sequencing device that can deliver high volumes of long-read sequence data. The benchtop GridION can run up to five MinION Flow Cells at a time, on-demand, for larger genomics projects. PromethION is the largest format for nanopore sequencing, designed to offer on-demand use of up to 48 flow cells—capable of delivering more than 10 Tb of sequence data in a full run—and is now being used in population-scale sequencing projects. The palm-sized PromethION 2 makes high-output nanopore sequencing broadly accessible.
To make the technology suitable for any user, they focus on increasing ease of use and automation. Nanopore sequencing offers easy and rapid preparation, including a ten-minute library preparation kit and the automated, programmable VolTRAX. Oxford Nanopore also provides a range of analysis workflows.
Website: nanoporetech.com
*Genotypic Technology is a certified exclusive distributor of Oxford Nanopore Technologies products and is authorized to distribute to in India.
